Teschendorf C - Search Results

1

Recombinant adeno-associated and adenoviral vectors for the transduction of pancreatic and colon carcinoma.

Teschendorf C, Warrington KH Jr, Shi W, Siemann DW, Muzyczka N. Teschendorf C, et al. Anticancer Res. 2006 Jan-Feb;26(1A):311-7. Anticancer Res. 2006. PMID: 16475712 Free article.

2

Adeno-associated virus-mediated gene transfer of endostatin inhibits angiogenesis and tumor growth in vivo.

Shi W, Teschendorf C, Muzyczka N, Siemann DW. Shi W, et al. Among authors: teschendorf c. Cancer Gene Ther. 2002 Jun;9(6):513-21. doi: 10.1038/sj.cgt.7700463. Cancer Gene Ther. 2002. PMID: 12032662

3

Comparison of the EF-1 alpha and the CMV promoter for engineering stable tumor cell lines using recombinant adeno-associated virus.

Teschendorf C, Warrington KH Jr, Siemann DW, Muzyczka N. Teschendorf C, et al. Anticancer Res. 2002 Nov-Dec;22(6A):3325-30. Anticancer Res. 2002. PMID: 12530082

4

Efficacy of recombinant adeno-associated viral vectors serotypes 1, 2, and 5 for the transduction of pancreatic and colon carcinoma cells.

Teschendorf C, Emons B, Muzyczka N, Graeven U, Schmiegel W. Teschendorf C, et al. Anticancer Res. 2010 Jun;30(6):1931-5. Anticancer Res. 2010. PMID: 20651336

5

Gene therapy delivery of endostatin enhances the treatment efficacy of radiation.

Shi W, Teschendorf C, Muzyczka N, Siemann DW. Shi W, et al. Among authors: teschendorf c. Radiother Oncol. 2003 Jan;66(1):1-9. doi: 10.1016/s0167-8140(02)00280-3. Radiother Oncol. 2003. PMID: 12559515

6

Developing VDEPT for DT-diaphorase (NQO1) using an AAV vector plasmid.

Warrington KH Jr, Teschendorf C, Cao L, Muzyczka N, Siemann DW. Warrington KH Jr, et al. Among authors: teschendorf c. Int J Radiat Oncol Biol Phys. 1998 Nov 1;42(4):909-12. doi: 10.1016/s0360-3016(98)00357-5. Int J Radiat Oncol Biol Phys. 1998. PMID: 9845120

7

Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models.

Vangala D, Ladigan S, Liffers ST, Noseir S, Maghnouj A, Götze TM, Verdoodt B, Klein-Scory S, Godfrey L, Zowada MK, Huerta M, Edelstein DL, de Villarreal JM, Marqués M, Kumbrink J, Jung A, Schiergens T, Werner J, Heinemann V, Stintzing S, Lindoerfer D, Mansmann U, Pohl M, Teschendorf C, Bernhardt C, Wolters H, Stern J, Usta S, Viebahn R, Admard J, Casadei N, Fröhling S, Ball CR, Siveke JT, Glimm H, Tannapfel A, Schmiegel W, Hahn SA. Vangala D, et al. Among authors: teschendorf c. Genome Med. 2021 Jul 16;13(1):116. doi: 10.1186/s13073-021-00926-7. Genome Med. 2021. PMID: 34271981 Free PMC article.

8

[Colorectal carcinoma in elderly patients].

Teschendorf C, Schmiegel W. Teschendorf C, et al. Praxis (Bern 1994). 2005 Dec 7;94(49):1957-61. doi: 10.1024/0369-8394.94.49.1957. Praxis (Bern 1994). 2005. PMID: 16416929 Review. German.

9

c-kit mutation and osteopetrosis-like osteopathy in a patient with systemic mast cell disease.

Reinacher-Schick A, Petrasch S, Longley BJ, Teschendorf C, Graeven U, Schmiegel W. Reinacher-Schick A, et al. Among authors: teschendorf c. Ann Hematol. 1998 Sep;77(3):131-4. doi: 10.1007/s002770050428. Ann Hematol. 1998. PMID: 9797083

10

5-Fluorouracil induces arterial vasocontractions.

Südhoff T, Enderle MD, Pahlke M, Petz C, Teschendorf C, Graeven U, Schmiegel W. Südhoff T, et al. Among authors: teschendorf c. Ann Oncol. 2004 Apr;15(4):661-4. doi: 10.1093/annonc/mdh150. Ann Oncol. 2004. PMID: 15033676 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters